Oral Wegovy (Semaglutide Pill) Introduction of the Wegovy pill in December 2025 introduced a new choice for those preferring oral intake as part of their weight management plan
In one study conducted in Australia, it was shown that 95% of participants using Melanotan II for 6 weeks achieved longer-lasting skin darkening after sun exposure
Medications in the GLP-1 receptor agonist category have been tied to pancreatitis and gallbladder complications
In the SURMOUNT trials, participants using the 15 mg dose experienced roughly 21% body weight loss over 72 weeks, compared to 16% at the 10 mg dose
Novo Nordisk's NovoCare offers similar savings for Wegovy
About EnsembleIQ EnsembleIQ is the premier resource of actionable connections and insightful information in North Americas retail, technology, consumer goods, healthcare, and hospitality sectors